APLM
Apollomics Inc. Class A Ordinary Shares
NASDAQ: APLM · HEALTHCARE · BIOTECHNOLOGY
$13.08
+1.75% today
Updated 2026-04-29
Market cap
$28.71M
P/E ratio
—
P/S ratio
3.19x
EPS (TTM)
$-7.57
Dividend yield
—
52W range
$4 – $40
Volume
0.0M
Apollomics Inc. Class A Ordinary Shares (APLM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-21.94M | $-35.68M | $-43.31M | $-42.82M | $-43.21M | $-28.74M | $-10.37M |
| Capital expenditures | $857000.00 | $144000.00 | $50000.00 | $367000.00 | $6000.00 | $24000.00 | $0.00 |
| Depreciation | $369000.00 | $4.39M | $681000.00 | $775000.00 | $669000.00 | $361000.00 | — |
| Stock-based comp | — | $4.51M | $8.12M | $3.58M | $12.69M | $10.93M | $-979000.00 |
| Free cash flow | $-22.80M | $-35.83M | $-43.36M | $-43.19M | $-43.22M | $-28.77M | $-10.37M |
| Investing cash flow | $-29.86M | $2.33M | $-38.95M | $29.05M | $21.36M | $5.98M | — |
| Financing cash flow | $9.51M | $125.51M | $-1.64M | $-294000.00 | $21.23M | $468000.00 | — |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |